Canadian Reactive Skin Decontaminant

Sabourin, C.L., Hayes T.L., and Snider T.H., 2001. A medical research and evaluation facility study on Canadian reactive skin decontamination lotion. Final report, USAMRICD, Edgewood Area, Aberdeen Proving Ground, MD. 

Reactive oximes and their salts, such as potassium 2,3-butanedione monoximate found in commercially available Reactive Skin Decontaminant Lotion (RSDL), are extremely effective at rapidly detoxifying sulfur vesicants. Some chloroisocyanurates, similar to those found in the Canadian Aqueous System for Chemical-Biological Agent Decontamination (CAS-CAD), are effective at detoxifying sulfur vesicants, and so is oxone, a peroxymonosulfate triple salt. 

Reactive Skin Decontamination Lotion (RSDL) has recently been approved for procurement by the U.S. military (F-Z-EM 2007). RSDL is currently marketed by E-Z-EM, Inc. and is a patented, broad spectrum, skin decontamination lotion that is used to remove or neutralize chemical threat agents and biological warfare agents such as trichothecene mycotoxin (T2 toxin), which can cause severe skin and eye irritation. RSDL was originally developed by the Canadian Defense Research Establishment and consists of 1.25 molar potassium 2,3-butanedione monoximate in poly-etheylene glycol monoethyl ethers with 10% w/v water (Sabourin et al. 2001 Lukey et al. 2004). 

---